Built on real project execution and business development experience, this series unpacks the business logic of outsourced drug development and manufacturing—covering technical positioning, client acquisition, pricing and cost structures, and long-term partnerships—to reveal how CDMOs truly create value.
Learn how to find and develop high-value clients in CDMO business development, from global conferences to LinkedIn. Practical tactics for 6–24 month sales cycles, with real lessons on technical positioning, trust-building, and resilience.
What does Business Development (BD) actually do in biotech and pharma? From licensing deals to M&A, learn about the 5 core BD functions, daily responsibilities, and how BD differs from sales. A practical guide from an industry BD professional.
Practical strategies for Regional CDMOs to accelerate to global market and overcome Western biotech hesitation. Learn how specialization, GMP certifications, strategic partnerships, and industry networking can help small to mid-sized CDMOs become trusted partners in US, EU, and Japanese markets
Despite solid technology and competitive pricing, many Asian CDMOs struggle to win global clients. Here explores 5 deep-rooted structural barriers — regulatory hurdles, reputation building, geopolitical risks, communication challenges — prevent Asian CDMOs from achieving true globalization.
Learn how to calculate product unit cost step-by-step—from direct and indirect manufacturing costs to unit pricing and profit margin. Essential guide for business development and manufacturing professionals.
How do contract manufacturers turn unprofitable orders into profits? Discover the real cost structure behind CDMO/OEM/ODM strategic underpricing and learn how operational cost management leads to profitability—even with underpriced deals.
